ARCC — Q2 2026 Financial Report Analysis
Q2 · Fiscal year 2026 · Published by Pham Hop
Ares Capital's net investment income rose 5% to $359M on a bigger portfolio, but a $21M fee reversal flattered it, valuation losses cut GAAP EPS to $0.24 from $0.52, and NAV per share fell to $19.35 as non-accruals rose to 2.4% of cost.
- Revenue
- $768M
- +3.1% YoY
- Net income
- $171M
- -52.6% YoY
- Diluted EPS
- $0.24
- -53.8% YoY
This period vs a year ago
- Same period last year
- This period
Year-ago figures (≈) are worked out from the growth rate the company reported. Each row has its own scale.
Overview
Ares Capital (ARCC), the largest publicly traded business development company (BDC — a fund that lends to mid-sized private companies and passes most of its income to shareholders as dividends), earned more from its loans in Q2 2026 but lost more on their value. Total investment income rose 3.1% to $768 million because the portfolio was about 9% bigger than a year earlier, even though the average yield on it fell from 10.1% to 9.5%. Net investment income — the interest and fees left after expenses, which is what pays the dividend — rose 5.0% to $359 million. But GAAP net income, which also counts gains and losses on the loans' value, fell 52.6% to $171 million, or $0.24 per share, because ARCC marked its portfolio down by a net $183 million. Net asset value per share — roughly what each share would be worth if the fund sold everything at its own valuations and paid off its debts — fell to $19.35 from $19.59 at the end of March and $19.90 a year ago.
At a glance
- $0.50 net investment income per share vs a $0.48 dividend. The dividend was covered this quarter, but only because a $21 million accounting reversal of a fee owed to the manager added about $0.03 per share; without it, NII would have been about $0.47.
- Non-accrual loans at 2.4% of cost, up from 1.8% at year-end. Non-accrual loans are loans that have stopped paying interest, so a rising share means more borrowers in trouble (1.4% at fair value, up from 1.2%).
- NAV per share $19.35, down 2.8% from $19.90 a year ago. Over six months, NAV fell $0.59 even though NII of $1.05 per share more than covered the $0.96 of dividends, because valuation losses of $0.68 per share outweighed the excess.
Key metrics
| Metric | Q2 2026 | Q2 2025 | YoY Change |
|---|---|---|---|
| Total investment income (revenue) | $768M | $745M | +3.1% |
| Net investment income (NII) | $359M | $342M | +5.0% |
| NII per share (calculated: NII ÷ weighted shares) | $0.50 | $0.49 | +2.0% |
| GAAP net income (net increase in stockholders' equity from operations) | $171M | $361M | −52.6% |
| GAAP EPS (basic and diluted) | $0.24 | $0.52 | −53.8% |
| Net realized and unrealized gains (losses) | −$188M | +$19M | n/m |
| Weighted average yield on portfolio (at cost) | 9.5% | 10.1% | −0.6 pts |
| Average portfolio size (at cost) | $29,662M | $27,180M | +9.1% |
| NAV per share (period-end) | $19.35 | $19.90 | −2.8% |
| Loans on non-accrual, % of portfolio at cost | 2.4% (Jun 30, 2026) | 1.8% (Dec 31, 2025) | +0.6 pts |
| Debt-to-equity (principal) | 1.15x (Jun 30, 2026) | 1.12x (Dec 31, 2025) | +0.03x |
| Dividend declared per share | $0.48 | $0.48 | flat |
"Net income" and "EPS" here are the GAAP lines: the net increase in stockholders' equity resulting from operations, and basic/diluted net income per share as reported. The 10-Q does not print a quarterly NII-per-share figure; the $0.50 and $0.49 are NII divided by the reported weighted average shares (718 million and 695 million). Non-accrual and leverage comparisons are to December 31, 2025, the comparison the filing gives.
Bigger portfolio, lower yields
The 10-Q attributes the rise in interest income "primarily [to] the increase in the average size of our portfolio, which was partially offset by lower yields." Average investments at cost grew to $29.7 billion from $27.2 billion, while the weighted average yield fell 0.6 percentage points to 9.5%. Most of ARCC's loans are floating-rate, so lower base rates and tighter lending spreads flow straight through: first-lien loans (the most senior, best-protected loans, about 59% of the portfolio at fair value) yielded 8.9% at amortized cost on June 30, down from 9.1% at year-end.
Funding the bigger portfolio cost more. Interest and credit facility fees rose 13.8% to $214 million, because average debt outstanding rose to $16.1 billion from $14.1 billion; the average interest rate on that debt was unchanged at 4.9%. The base management fee paid to the external manager, Ares Capital Management, rose to $110 million from $104 million with the portfolio. So income grew $23 million, but the extra $26 million of interest cost more than used it up; NII still rose because of a fee reversal explained below.
Fee income helped. Capital structuring service fees (one-time fees ARCC charges when it arranges a loan) rose to $39 million from $33 million, which the filing says was "primarily due to an increase in the weighted average capital structuring fee percentage" (2.1% vs 1.5%), partly offset by fewer new commitments eligible for that fee. Recurring dividend income fell to $66 million from $75 million "primarily due to a decrease in yielding preferred equity investments." Interest from controlled affiliates rose to $59 million from $40 million, mainly reflecting more lending to Ivy Hill Asset Management (IHAM), ARCC's wholly owned asset manager: ARCC funded $554 million into IHAM this quarter vs $155 million a year ago.
Credit: more loans on the watch list
ARCC's manager grades every investment from 4 (best) to 1 (likely loss). Between December 31 and June 30, the two weakest grades grew:
| Grade (fair value) | Jun 30, 2026 | Dec 31, 2025 |
|---|---|---|
| Grade 2 (risk "increased materially") | $1,089M (3.7%) | $675M (2.3%) |
| Grade 1 (likely loss of cost basis) | $493M (1.7%), 33 companies | $448M (1.5%), 25 companies |
| Non-accrual, % at cost / at fair value | 2.4% / 1.4% | 1.8% / 1.2% |
The gap between non-accruals at cost (2.4%) and at fair value (1.4%) shows that ARCC has already written those loans down well below what it lent. The weighted average grade stayed at 3.1.
The quarter's $191 million of net unrealized losses on investments came from gross markdowns of $408 million against $265 million of markups. The largest named markdowns were Cornerstone OnDemand (−$43 million), Symplr Software (−$23 million), Denali Intermediate Holdings (−$20 million) and Essential Services Holding (−$20 million), offset partly by Arxis (+$35 million) and SageSure (+$17 million). Realized results were close to flat (−$7 million on investments): a $43 million gain on Global Medical Response was more than offset by a $70 million loss on Eagle Football Holdings. Software and services remains the largest industry exposure at 22.0% of the portfolio at fair value, down from 23.8% at year-end, and the 10-Q now lists "the impact of the development and use of artificial intelligence and potential impact to certain of our portfolio companies" among its forward-looking risks.
Shrinking, not growing, this quarter
ARCC made $2.59 billion of new commitments, about the same as a year ago ($2.57 billion), but exits and repayments jumped to $2.92 billion from $1.96 billion, leaving net commitments of −$323 million vs +$610 million in Q2 2025. In dollars actually lent and returned, $2.93 billion was funded and $3.04 billion was sold or repaid. New money went out at a 9.4% yield, slightly above the 9.1% on what came back, but well below the 9.9% on new loans a year ago. Total investments at fair value ended at $29.3 billion vs $29.5 billion at year-end.
Leverage edged up to 1.15x debt-to-equity from 1.12x at year-end — partly because equity shrank as NAV fell. Asset coverage (the legal test that assets must be at least 150% of borrowings) was 186%, and ARCC had about $6.7 billion of undrawn credit facility capacity plus $383 million of cash.
What the headline numbers hide
- NII was lifted by an accounting reversal. The "capital gains incentive fee" is a fee the manager earns on cumulative gains; under GAAP it is accrued (or reversed) every quarter as portfolio values move. With values falling, ARCC reversed $21 million of that accrual in Q2 2026 (and $82 million over six months), which reduced expenses, against a $4 million charge in Q2 2025. The 10-Q notes that "there was no capital gains incentive fee actually payable" at June 30. Strip it out on both sides and NII falls to about $338 million from $346 million, or roughly $0.47 per share vs $0.50 — down, not up, and just below the $0.48 dividend.
- Dividend coverage is thinner than it looks. On reported NII, Q2 coverage was about 104% ($0.50 / $0.48). On NII excluding the fee reversal, it is about 98%. Over the six months reported NII per share was $1.05 vs $0.96 paid, but $82 million of that came from the same reversal — about $0.11 per share.
- Per-share figures are diluted by more shares. Weighted shares rose to 718 million from 695 million, so NII grew 5.0% in dollars but only about 2% per share. No new shares were issued in the first half of 2026.
- The GAAP collapse is mostly valuation, not cash losses. Of the $188 million net loss on investments, $183 million was unrealized (marks on loans still held); realized losses were $5 million. Unrealized losses can reverse if borrowers recover, but the rising grade 1 and 2 buckets suggest some will turn into realized ones.
- Cash flow isn't a useful earnings check here. For a BDC, "operating" cash flow includes loans made and repaid, so the six-month figure (+$520 million vs −$517 million a year ago) mostly reflects the portfolio shrinking slightly, not earnings quality.
- Last year's comparison had its own one-offs. Q2 2025 GAAP income included a $112 million realized loss on the Senior Direct Lending Program and $44 million of tax on realized gains, offset by large gains on SageSure ($68 million) and Redwood Services ($64 million).
Takeaway: ARCC's earnings power is flat to slightly down once you remove a $21 million fee reversal: falling loan yields (9.5% vs 10.1%) and higher interest costs absorbed the benefit of a 9% bigger portfolio, while rising non-accruals (2.4% at cost) and valuation losses pushed NAV per share down 2.8% in a year. The $0.48 dividend is still roughly covered, but with almost no cushion.
Outlook
ARCC does not give earnings guidance. Management's macro read in the 10-Q is cautious-positive: U.S. leveraged credit "generated positive total returns, supported by stable economic growth and balanced labor market conditions," and "underlying fundamentals are supportive of continued stability." Early Q3 activity shows a better yield picture: from July 1 to July 23, ARCC made $244 million of new commitments at a 10.2% yield on funded debt while exiting $132 million at 8.3%, and it reported a $1.5 billion investment backlog. As of July 23 the stock traded at $18.61, about 3.8% below June 30 NAV.
Our read: the near-term direction of NII depends on whether new loans keep pricing above the ones being repaid — the July data says yes, the Q2 data said only marginally. The bigger swing factor is credit. Grade 1 and 2 investments rose to 5.4% of the portfolio from 3.8% in six months, and software, the largest sector, carries the AI-disruption risk the company itself now flags. If non-accruals keep climbing, the fee-reversal cushion that propped up NII in the first half disappears once the accrual reaches zero, and the $0.48 dividend would rest on NII of about $0.47. The quarters to watch are whether non-accruals at cost stop rising from 2.4% and whether NII excluding the capital gains fee gets back above $0.48.